| abstract |
Provided herein are methods for treating abnormal inflammatory and inflammatory conditions, comprising mucosal administration of an effective amount of interleukin (eg, IL-2) or a fragment or derivative of interleukin. Also provided herein is a pharmaceutical composition for mucosal administration to treat abnormal inflammation and inflammatory conditions, the composition comprising the interleukin or fragment or derivative. |